Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Literature
1.
Knower KC, Chand AL, Eriksson N, Takagi K, Miki Y, Sasano H, Visvader JE, Lindeman GJ, Funder JW, Fuller PJ et al (2013) Distinct nuclear receptor expression in stroma adjacent to breast tumors. Breast Cancer Res Treat 142(1):211–223PubMedCrossRef
2.
Boyd M, Hildebrandt RH, Bartow SA (1996) Expression of the estrogen receptor gene in developing and adult human breast. Breast Cancer Res Treat 37(3):243–251PubMedCrossRef
3.
Keeling JW, Ozer E, King G, Walker F (2000) Oestrogen receptor alpha in female fetal, infant, and child mammary tissue. J Pathol 191(4):449–451PubMedCrossRef
4.
Koerner F, Oyama T, Kurosumi M, Maluf H (2001) Ovarian hormone receptors in human mammary stromal cells. J Steroid Biochem Mol Biol 78(3):285–290PubMedCrossRef
5.
Madeo A, Maggiolini M (2010) Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. Cancer Res 70(14):6036–6046PubMedCrossRef
6.
Palmieri C, Saji S, Sakaguchi H, Cheng G, Sunters A, O’Hare MJ, Warner M, Gustafsson JA, Coombes RC, Lam EW (2004) The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts. J Mol Endocrinol 33(1):35–50PubMedCrossRef
7.
Sasano H, Suzuki T, Matsuzaki Y, Fukaya T, Endoh M, Nagura H, Kimura M (1999) Messenger ribonucleic acid in situ hybridization analysis of estrogen receptors alpha and beta in human breast carcinoma. J Clin Endocrinol Metab 84(2):781–785PubMed
8.
Walker KJ, McClelland RA, Candlish W, Blamey RW, Nicholson RI (1992) Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue. Eur J Cancer 28(1):34–37PubMedCrossRef
9.
Jensen EV, Cheng G, Palmieri C, Saji S, Makela S, Van Noorden S, Wahlstrom T, Warner M, Coombes RC, Gustafsson JA (2001) Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci USA 98(26):15197–15202PubMedCrossRef
10.
Crandall DL, Busler DE, Novak TJ, Weber RV, Kral JG (1998) Identification of estrogen receptor beta RNA in human breast and abdominal subcutaneous adipose tissue. Biochem Biophys Res Commun 248(3):523–526PubMedCrossRef
11.
Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Warri A, Weihua Z, Van Noorden S, Wahlstrom T, Coombes RC, Warner M et al (2002) Estrogen receptor beta in breast cancer. Endocr Relat Cancer 9(1):1–13PubMedCrossRef
12.
Leygue E, Dotzlaw H, Watson PH, Murphy LC (1999) Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue. Cancer Res 59(6):1175–1179PubMed
13.
Skliris GP, Carder PJ, Lansdown MR, Speirs V (2001) Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profiling? Br J Cancer 84(8):1095–1098PubMedCentralPubMedCrossRef
14.
Shaaban AM, Green AR, Karthik S, Alizadeh Y, Hughes TA, Harkins L, Ellis IO, Robertson JF, Paish EC, Saunders PT et al (2008) Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients. Clin Cancer Res 14(16):5228–5235PubMedCrossRef
Metadata
Title
Estrogen receptor status of breast stromal cells
Authors
Kevin C. Knower
Ashwini L. Chand
Colin D. Clyne
Publication date
01-02-2014
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2014
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-2837-6

Other articles of this Issue 3/2014

Breast Cancer Research and Treatment 3/2014 Go to the issue

Preclinical study

Progesterone stimulates progenitor cells in normal human breast and breast cancer cells

Epidemiology

Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers

Clinical trial

Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care

Clinical Trial

Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2

Letter to the Editor

Steroid hormone receptor expression in breast cancer stroma

Epidemiology

Treatment and outcomes in diabetic breast cancer patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits